Colace and Polatuzumab Vedotin-piiq

• Generic Name: docusate
• Dosage Forms: n.a.
• Other Brand Names: Colace, Colace Microenema, Enemeez Mini, Diocto, Doc-Q-Lace, Docu, Doculase, Docusil, Docusoft S, DocuSol, Dulcolax Stool Softener, Kao-Tin, Pedia-Lax Stool Softener, Phillips Stool Softener, Promolaxin, Silace, Surfak Stool Softener, Sur-Q-Lax, Dialose, DC-240, Kasof, DOK, Sulfalax Calcium, DOS, DSS, Modane Soft, Regulax SS, Dioeze, Aqualax, Dioctocal, Dioctosoftez, Dioctyn, Dionex, Docu Soft, Docucal, Calcium Stool Softener, Calube, D-S Caps, Ex-Lax Stool Softener, Genasoft, Doss-Relief, Fleet Sof-Lax, Colace Micro-Enema, Correctol Softgel Extra Gentle, Therevac-SB, Octycine-100, Octycine-250, Sulfolax, Kaopectate Stool Softener, Vacuant, Docuprene, DocuSol Kids, Colace Clear, Docusate Mini, Surfak

Colace (docusate) is a stool softener. It makes bowel movements softer and easier to pass.

Colace is used to treat or prevent occasional constipation, and to reduce pain or rectal damage caused by hard stools or by straining during bowel movements.

Colace may also be used for purposes not listed in this medication guide.

• Generic Name: polatuzumab vedotin
• Dosage Forms: n.a.
• Other Brand Names: Polivy

Polatuzumab vedotin-piiq is a CD79b-directed antibody–drug conjugate indicated in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, after at least two prior therapies.

Accelerated approval was granted for this indication based on complete response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.